Ergomed and Ferrer to Develop Lorediplon for Insomnia

Ergomed Clinical Research Ltd, a leading clinical development company working with biotechnology and pharmaceutical companies, today announces that it has entered into an agreement with Ferrer, a privately-held Spanish pharmaceutical company, to support further clinical studies of Lorediplon in patients with insomnia. Ferrer also announced it is collaborating with Ildong Pharmaceuticals Co Ltd, Korea.